Generation of PA (phosphatidic acid) by PLD (phospholipase D)-catalysed hydrolysis of phosphatidylcholine plays a pivotal role in cellular signalling pathways that regulate organization of the actin cytoskeleton, vesicular transport and exocytosis and stimulation of cell growth and survival. PLD regulation and function are intimately linked with phosphoinositide metabolism. Phosphatidyl 4-phosphate 5-kinase is stimulated by PA in vitro and this enzyme is the downstream effector of a signifi cant subset of PLD signalling pathways. Yeast and mammalian PLDs are potently and specifi cally activated by the product of this kinase, PtdIns(4,5)P 2 , through interactions mediated by a polybasic motif within the catalytic core of the enzyme. Integrity of this motif is critical for agonist activation of mammalian PLD and for PLD function in secretion, sporulation and exocytosis in vivo. Although dispensable for catalysis in vitro, these PLD enzymes also contain N-terminal PH (pleckstrin) and PX (phox) homology domains. Binding studies using recombinantly expressed PLD fragments indicate that the PH and PX domains also interact specifi cally with distinct phosphoinositide ligands. Both the PX and PH domains are important for PLD function by controlling the dynamic association of the enzyme with the plasma membrane and its intracellular traffi cking by the endocytic pathway. These results identify two distinct modes of regulation of PLD by phosphoinositides: stimulation of catalysis mediated by the polybasic domain and dynamic regulation of membrane targeting mediated primarily by the PH and PX domains.
Introduction
PC (phosphatdidylcholine)-specifi c PLD (phospholipase D) is a glycerophospholipid phosphodiesterase that catalyses hydrolysis of its substrate to generate PA (phosphatidic acid) and choline. Although fi rst identifi ed in plants, PLD activities are now known to be present in essentially every biological system examined [1] . While PLD probably plays a 'housekeeping' role in phospholipid synthesis, turnover and membrane remodelling, the sustained interest in these enzymes in eukaryotes stems from their roles in cell signalling and cell regulation. PLD activity is tightly controlled. Mammalian PLD activity is rapidly increased in many cell types in response to activation of cell surface receptors for a wide range of hormones, neurotransmitters and growth factors. Direct regulation of PLD by protein kinases, small GTPases and other interacting proteins couples cell surface receptors to activation of intracellular PLD activity. PLD-generated PA is an intracellular signalling lipid that regulates the actin cytoskeleton and controls pathways that regulate cell growth and survival. Perhaps more signifi cantly, a growing body of experimental evidence, which is rapidly being augmented by mechanistic insights, implicates PLD as a vital regulator of both constitutive and agonist-promoted intracellular vesicle traffi cking [1, 2] . Several recent reviews discuss the structure, regulation and functions of PLD. This short article focuses on the role of phosphoinositides as regulators of yeast and mammalian PLD activity and function and, in particular, on mechnaisms responsible for targetting these extrinsic membrane proteins to different intracellular membrane compartments.
Yeast and mammalian PLDs are activated by PtdIns(4,5)P 2
In the early 1990s, several groups observed that PLD activity in broken cell assay systems was stimulated by hydrolysis-resistant GTP analogues [3] [4] [5] [6] . Surprisingly, this effect did not appear to directly involve the α-subunits of heterotrimeric G-proteins, but reconstitution studies identifi ed small GTPases of the ARF (ADP-ribosylation factor) and Rho families as GTP-dependent activators of PLD. The molecular characterization of eukaryotic PLDs identifi ed PLD1 as the target of these small GTPases while the other widely expressed mammalian PLD, PLD2, was refractory to stimulation by these activators [7] [8] [9] . The prototypic eukaryotic PLD, the product of the budding yeast Spo14 gene is also insensitive to activation by these GTPases [10, 11] . The development of in vitro assay systems for measurement of PLD using completely artifi cial substrate preparations was a key step in the 'reconstitution' experiments that identifi ed these PLD regulators. Brown, Sternweis and colleagues [5] observed that mammalian PLD activity was low against sonicated dispersions of mixtures of the PC substrate and PE (phosphatidylethanolamine) but that activity was signifi cantly increased when PtdIns(4,5)P 2 was included in these substrate preparations [5] . This PLD activity (later ascribed to PLD1) was concurrently activated by ARF. Although PtdIns(4,5)P 2 can promote ARF activation by stimulating guanine nucleotide exchange, the effect of PtdIns(4,5)P 2 appeared to be exerted
How do phosphoinositides activate PLD?
Only phosphoinositides with a vicinal 4,5-phosphate pair activate PLD1, PLD2 and Spo14p. PtdIns(3,4,5)P 3 was found to be approximately equipotent with PtdIns(4,5)P 2 but approx. 50% as effi cacious. Other phosphoinositides were ineffective as were a range of anionic lipids including PA. Water soluble inositol phosphates and glycerophosphoinositol phosphates neither activate PLD nor inhibit the activation of PLD by PtdIns(4,5)P 2 [5, [8] [9] [10] 14, 15] . PLD2 expressed in insect cells using a baculovirus vector and purifi ed from the cytosolic fraction of these cells binds weakly to large unilamellar vesicles of pure PC. Binding is increased appreciably when acidic lipids are incorporated into these vesicles, with an additional specifi c increase in binding affi nity observed when PtdIns(4,5)P 2 is included in the vesicles [16] . A similar PtdIns(4,5)P 2 -dependent increase in binding affi nity was exhibited by an enzymatically active mutant of PLD1 lacking the N-terminus and inter catalytic domain 'loop' region and, more recently, using another deletion mutant of PLD1 [17, 18] . The specifi c increase in binding affi nity indicates that these PLD enzymes can bind to PtdIns(4,5)P 2 in the bilayer surface of these liposomes. Like other phospholipases, PLDs are interfacial enzymes [18] . High levels of activity require that the enzyme associates with a substrate-containing interface where it can function in a processive mode of catalysis performing multiple rounds of substrate hydrolysis before it dissociates. PtdIns(4,5)P 2 could therefore activate PLD by simply anchoring the enzyme to the lipid surface and promoting this processive catalysis in a similar manner to that described for phosphoinositide-specifi c PLCδ which associates with substrate-containing lipid surfaces through its N-terminal PH (pleckstrin homology) domain [19] . As noted above, PLD1 and PLD2 exhibit signifi cant binding to liposomes containing acidic phospholipids. To test the hypothesis that PtdIns(4,5)P 2 activates PLD2 solely by anchoring the enzyme to the liposome surface we compared PLD2 activity and binding to liposomes of PC, PE and PS (phosphatidylserine, molar ratio 1:1:1) containing either no additional lipid, 5% PtdIns(4,5)P 2 or 10% PA. PLD binding to a fi xed concentration of these liposomes (100 µM total lipid) was assessed by measuring PLD activity remaining in the supernatant after the liposomes had been sedimented by centrifugation. While negligible binding of PLD2 was detected to pure PC liposomes, approx. 45% of the input enzyme bound to the PC/PS/PE liposomes and this value was increased to approx. 90% when either 5% PtdIns(4,5)P 2 or 10% PA were included. In parallel experiments we prepared liposomes containing radiolabelled PC substrate and measured PLD2 activity against this substrate by monitoring release of water-soluble choline. PLD2 activity against substrate in PC/PS/PE liposomes was very low, even though a signifi cant fraction of the enzyme was bound to the liposomes. More dramatically, although comparable levels of PLD2 were bound to vesicles containing PA as were bound to vesicles containing PtdIns(4,5)P 2 , activity against the PA-containing vesicles was low and comparable to that observed against substrate in the PC/PS/PE liposomes ( Figure 1 ). These data strongly suggest that the increase in PLD activity observed using substrate preparations containing PtdIns(4,5)P 2 is not simply a result of increased PLD binding to these vesicles. These observations support the idea that activation of PLD activity by PtdIns(4,5)P 2 involves an as yet undefi ned allosteric mechanism.
What is the structural basis for phosphoinositide activation of PLD?
The liposome binding studies described above indicate that PLD1 and PLD2 bind to PtdIns(4,5)P 2 in a bilayer interface. Surface plasmon resonance studies using supported lipid monolayers also revealed a specifi c association between PLD1 and phosphoinositides including PtdIns(4,5)P 2 [20] . PLD2 can PLD2 was expressed in insect cells and purifi ed and sucrose-loaded liposomes of the indicated compositions were prepared as described previously [16] . PLD2 binding was measured by monitoring PLD2 activity remaining in the supernatant after sedimentation of the liposomes by ultracentrifugation. PLD activity was measured against liposomes of identical compositions containing [ be activated by photoreactive benzophenone derivatives of PtdIns(4,5)P 2 , and a radioactive form of one of these derivatives was used to label the protein in a manner that could be protected by an excess of PtdIns(4,5)P 2 but not by other phosphoinositides or other acidic lipids that do not activate the enzyme [16] . Taken together, these results strongly suggested that a binding interaction between the PLD enzymes and PtdIns(4,5)P 2 is important for stimulation of catalysis by this lipid.
PLD1, PLD2 and Spo14p have a common multidomain structure. Their catalytic core contains tandem HKD or PLD catalytic domains fl anked by PLD-specifi c sequences that are also critical for catalysis. The C-terminus of the proteins is divergent in primary sequence and does not contain recognizable homologies to other proteins. However, the N-termini contain both a PX (phox homology) and PH domains (Figure 2 ) [1] . Although there is variation in their ligand specifi city and affi nity, examples of both PX and PH domains have been shown to bind to phosphoinositides and inositol phosphates [21] . However, the entire N-terminus of PLD1 and PLD2 is completely dispensable for catalysis and, in both cases, deletion mutants of the enzymes are activated by PtdIns(4,5)P 2 with a potency and effi cacy that is indistinguishable from that of their wild-type counterparts [22] [23] [24] . Although we now know that the PLD PX and PH domains can bind phosphoinositides and play important roles in targeting the enzymes to different membrane compartments in the cell, which is also a critical determinant of PLD activity and function (see below), they are however not required for stimulation of catalysis by PtdIns(4,5)P 2 in these in vitro assays. A structurally and functionally diverse range of proteins, most notably regulators of cytoskeletal organization, have been found to bind to and be regulated by PtdIns(4,5)P 2 through interactions that are mediated by sequence motifs enriched in basic and aliphatic amino acids [25] . PLD1, PLD2 and Spo14p contain a number of candidate sequences that could potentially function in this manner. Mutational studies in which these sequences were targeted by mutation to replace conserved basic amino acids with neutral glycine residues identifi ed residues within a polybasic motif embedded in the catalytic domain of the enzymes that were required for both association of the enzymes with and activation by PtdIns(4,5)P 2 . In the case of PLD2, mutation of this motif reduced binding affi nity of the protein for liposomes containing PtdIns(4,5)P 2 and resulted in a signifi cant attenuation of the activation of the enzyme by this lipid. Mutation of the cognate motif in both PLD1 and Spo14p also reduced stimulation of catalysis by PtdIns(4,5)P 2 [16] . Although diffi culties in expressing suitable fragments of any of the PLD enzymes have precluded more detailed studies of the interaction of this region of the proteins with phosphoinositides, studies using synthetic peptides corresponding to this polybasic motif support the idea that this region of the proteins has the capacity to bind PtdIns(4,5)P 2 . Like PLD2, the polybasic motif peptides bind weakly to PC vesicles, but with signifi cant affi nity to PC vesicles containing 1% PtdIns(4,5)P 2 . Energetic calculations indicate that both the basic and aromatic residues present in this motif must contribute signifi cantly to the observed binding affi nity. The polybasic motif peptide can also sequester PtdIns(4,5)P 2 when added to phospholipid monolayers, as measured by monitoring accessibility of the lipid to hydrolysis by PLC (phosphoinositide-specifi c phospholipase C) [26] . Taken together, these results indicate that the polybasic motif is required for activation of PLD1, PLD2 and Spo14p by PtdIns(4,5)P 2 and suggest that this motif could contribute signifi cantly to mechanisms targeting the enzyme to PtdIns(4,5)P 2 , enriched intracellular membranes.
Is the requirement for PtdIns(4,5)P 2 exhibited by PLD1, PLD2 and Spo14p observed in vitro important for regulation of PLD in vivo?
As discussed above, PtdIns(4,5)P 2 is clearly an important regulator of PLD1, PLD2 and Spo14p when these enzymes are assayed in vitro using artificial substrate preparations. The availability of mutant alleles of these enzymes with attenuated responses to PtdIns(4,5)P 2 provided valuable tools to examine the requirement for PtdIns(4,5)P 2 in PLD regulation and function in vivo. PLD2 mutants with non-conservative substitution of lysine residues within the polybasic motif were expressed in several mammalian cell lines at comparable levels with the wild-type enzyme. The wild-type and mutant enzymes were predominantly membrane associated and exhibited indistinguishable subcellular localization being predominantly found at the plasma membrane and associated with cytoplasmic vesicles. Both wild-type and polybasic motif mutant PLD2 also exhibited partial localization to detergent-resistant membrane domains. Whereas the wild-type enzyme had readily measurable activity against endogenous substrates that could be further stimulated by phorbol esters, the polybasic motif mutant PLD2 was inactive [16] . Polybasic domain mutants of PLD1 also exhibit low activity when expressed in several cell types. However, in contrast with PLD2, polybasic motif mutants of PLD1 exhibit a different localization pattern to that observed with wild-type PLD1, being predominantly cytosolic and refractory to agonist or phorbol ester promoted recruitment to the plasma membrane [27] . Whereas overexpression of wild-type PLD1 enhances exocytosis in adrenal chromaffi n cells, the polybasic domain mutant of PLD1 fails to promote this process, which may be a consequence of this mislocalization or of its reduced activity [28, 29] . Polybasic motif mutants of Spo14 appear to localize normally in vegetative and sporulating yeast, in the latter case, localizing to the prospore membrane. However, polybasic motif spo14 mutants could not complement the sporulation defect of Spo14 null strains or fulfi ll the essential requirement of Spo14 for secretion during 'sec14 bypass' [16] . Taken together, these results identify a critical role for stimulation of catalysis of these PLD enzymes mediated by the polybasic domain in PLD function in yeast and mammalian cells.
What is the function of the N-terminal PX and PH domains?
Although not recognized in the initial reports of the enzymes, PLD1, PLD2 and Spo14p contain tandem N-terminal PX and PH domains [1] (Figure 2 ). The PX domains of PLD1 and PLD2 are highly homologous to PX domains that have been shown to bind phosphoinositides and contain cationic residues in the ligand binding pocket that, in other examples of this motif, form electrostatic interactions with the phosphate groups of phosphoinositide ligands [21] . Studies conducted using surface plasmon resonance or a liposome sedimentation assay indicate that the isolated PLD1 PX domain binds to PtdIns(3,4,5)P 3 with high specifi city and has a more moderate non-specifi c affi nity for other acidic lipids [30, 31] . In contrast, the PLD1 PX domain was suggested to bind selectively to PtdIns5P in binding assays using phospholipids immobilized on nitrocellulose [28] . Similar studies have not yet been conducted using the PLD2 or Spo14 PX domains.
The PH domains of PLD1, PLD2 and Spo14p also exhibit considerable primary sequence similarity to PH domains from other proteins that bind phosphoinositides. Deletion of the PLD1 PH domain was reported to reduce binding of the enzyme to PtdIns(4,5)P 2 -containing lipid monolayers [20] . A purifi ed PLD2 PH domain-containing fragment bound to PtdIns(4,5)P 2 -containing liposomes with moderate affi nity but high selectivity [26] . Taken together, these results suggest that, although not obligatory for stimulation of catalysis by phosphoinositides, the PX and PH domains could play critical roles in targeting these PLD enzymes to phosphoinositide-rich membrane compartments. Several lines of evidence support this idea. PLD1 mutants, in which conserved lysine or arginine residues within the PX domain that were postulated to be important for phosphoinositide binding were substituted with alanine residues, exhibited reduced activity when expressed in fi broblasts. Deletion of the PLD1 PH domain or mutation of the PLD2 PH domain to either disrupt integrity of the motif or replace residues postulated to play critical roles in phosphoinositide binding resulted in enzymes that were catalytically inactive when expressed in several different cell types [20, 26, 28] .
What role do phosphoinositides play in membrane targeting and intracellular traffi cking of PLD?
PLD1 and PLD2 behave as tightly bound extrinsic membrane proteins. Biochemical fractionation studies indicate that almost all endogenous or overexpressed PLD1 or PLD2 protein and activity is membrane associated in many cells. Subcellular localization studies conducted using epitope tagged variants of the proteins, in some cases augmented by analyses using PLD1 or PLD2 selective antibodies, reveal that the proteins exhibit complex and cell-specifi c localization patterns. As a broad generalization, PLD1 exhibits variable distribution between the plasma membrane and intracellular membrane compartments that include the endoplasmic reticulum, Golgi apparatus and cytoplasmic vesicles that have previously been identifi ed as secretory lysosomes or endosomes. PLD2 generally exhibits a more pronounced plasma membrane localization, although distribution of the enzyme to intracellular membrane compartments is also commonly observed [9, [32] [33] [34] [35] [36] . The subcellular localization of PLD1 has been reported to be regulated by both physiological and pharmacological agonists in a variety of cell types. Whereas serum starvation drives localization of this PLD enzyme to intracellular membrane compartments, agonist activation of cells results in a dramatic recruitment of the enzyme to the plasma membrane [28, 32] . Clearly the PX, PH and polybasic motifs of these proteins are attractive candidates to mediate the selective recruitment and sorting of PLD1 and PLD2 to different membrane compartments within the cell. However, analysis of the membrane targeting of PLD1 and PLD2 is complicated by the fi nding that the PH domains of both PLD1 and PLD2 contain conserved cysteine residues that have been reported to be sites of palmitoylation [33, 37] . The binding studies described above were performed using either a truncation mutant of PLD1 that lacks the PH domain or recombinantly expressed PLD2 that was purifi ed from the cytosolic fraction of insect cells and is therefore not palmitoylated. However, based solely on energy considerations, palmitoylation would be suffi cient to anchor the enzymes to a membrane independently of interactions with phosphoinositides. Palmitoylation is a reversible post-translational modifi cation that determines the membrane targeting of a growing range of extrinsic membrane proteins. Although the dynamics of palmitoylation of PLD1 and PLD2 have not yet been explored, any model for the subcellular localization and traffi cking of these enzymes has to consider the potential implications of these observations.
With one exception, mutation or deletion of the PLD1 PX domain has been reported to have a very modest effect on the subcellular localization of PLD1. Like the wild-type enzyme, PLD1 PX domain mutants were predominantly cytosolic in resting cells and recruited to the plasma membrane upon agonist activation. However, mutation of the PLD1 PX domain impaired endocytosis of the enzyme after agonist-stimulated recruitment to the plasma membrane [28, 30] . Deletion of the entire PH domain from PLD1 increases cytoplasmic localization of the protein and attenuates both agonist-induced plasma membrane recruitment and subsequent endocytosis. This requirement for the PLD1 PH domain in endocytosis was suggested to be mediated by palmitoylation of cysteine residues within the domain, resulting in recruitment of the enzyme to cholesterol-and sphingolipid-enriched lipid rafts which are known to be sites of endocytosis [28] . Consistent with these observations, mutation of the PLD2 PH domain prevents localization of the protein to detergent-resistant membrane domains. However, in contrast with the observations made with PLD1, unlike wild-type PLD2 which localizes to the plasma membrane, PLD2 PH domain mutants localize to a cytoplasmic membrane compartment that partially corresponds to early endosomes [26] . In light of the weak but selective binding of the PLD2 PH domain to PtdIns(4,5)P 2 , these results suggest that the PLD2 PH domain and polybasic motif may function in tandem to target PLD2 to the plasma membrane. As suggested for PLD1, other determinants, possibly the PX domain, may control recruitment of PLD2 to sites of endocytosis. Figure 3 presents a model for how coordinated lipid binding activities of the polybasic, PH and PX domains in conjunction with regulated palmitoylation of the PH domain may coordinate the distribution of PLD1 and PLD2 between the plasma membrane and intracellular membrane compartments [28] .
Conclusion
Stimulation of catalysis by PtdIns(4,5)P 2 is a hallmark feature of yeast and mammalian PLDs. This aspect of PLD regulation is critical for PLD function in vivo and interactions with PtdIns(4,5)P 2 and other phosphoinositides clearly also determine PLD activity and function by controlling the subcellular distribution and intracellular traffi cking of the enzymes through mechanisms that involve coordinated binding of these lipids to both the polybasic motif responsible for stimulation of catalysis and to the N-terminal PH and PX domains. Although signifi cant progress has been made in identifying sequence determinants required for activation of PLD1, PLD2 and Spo14p by phosphoinositides, further details of this activation mechanism will require high resolution structures of these enzymes alone and in complex with their lipid regulators.
